Funded Tech Companies
Spero Therapeutics
Operating out of Cambridge, Spero Therapeutics has funding from GV, Rock Springs Capital and RA Capital.
Company Overview
Company Name
Spero Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
675 Massachusetts Ave. 14th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Spero Therapeutics' (Nasdaq: SPRO) vision is to find, develop, and advance groundbreaking therapeutics to meet critical patient needs in infectious disease using a unique business and drug discovery model. Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/2/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ankit Mahadevia
Chief Financial Officer
Joel Sendek
Chief Medical Officer
David Melnick
Chief Operating Officer
Cristina Larkin
Chief Scientific Officer
Thomas Parr
VP - Bus. Development
Timothy Keutzer
VP - Bus. Development
Scott Peterson
VP - Finance
Steve Garbacz
VP - R & D
Troy Lister
VP - Regulatory Affairs
Carol Waldo
Company Investors
- GV (Krishna Yeshwant)
- Rock Springs Capital
- RA Capital
- SR One Capital Management (Vikas Goyal)
- The Kraft Group
- Merck Capital Ventures (John Resnick)
- Lundbeckfond Ventures (Casper Breum)
- Atlas Venture (Jean-Francois Formela)
- Partners Innovation Fund (Reza Halse)
- Merck Capital Ventures (Josh Resnick)
- Atlas Venture (Jean-François Formela)
Browse more funded tech companies:
Speranza Systems | SpeSo Health
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs